BeStock  
Stocks › NAMS

NewAmsterdam Pharma NAMS

US equityMarket cap rank #2565Biotechnology
$22.80 −$0.40 (-1.72%)
Pre-market · Oct 6, 8:40 am ET · After hours $22.80 0.00%
Open$22.84
Prev close$23.20
Day range$22.23 – $23.34
Volume1.18M
Market cap$2.73B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$22.50M-50.6% YoY
Operating profit-$225.68M-28.0% YoY
Net profit-$203.82M+15.6% YoY
Diluted EPS-$1.72+32.8% YoY
Free cash flow-$39.29M-4.1% YoY
Operating cash flow-$39.21M

Free cash flow by quarter

$-12.6MSep '24$-37.5MDec '24$-36.5MMar '25$-37.8MJun '25$-32.8MSep '25$-41.0MDec '25$-30.6MMar '26$-39.3MJun '26

Annual revenue

$0.0FY20$0.0FY21$102.7MFY22$14.1MFY23$45.6MFY24$22.5MFY25

Profitability & balance sheet

Operating margin-1,002.9%
Net margin-905.7%
Return on equity-28.3%
Return on assets-24.9%
Return on invested capital-32.1%
Current ratio7.88
Liabilities / assets11.2%
Cash & investments$636.24M
Total debt$66,000.00
Net cash (debt)$636.18M

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Ending Cash Balance $425.51M $458.94M $491.32M $539.72M $563.86M
Net Cash Flow from Continuing Investing Activities -$4.76M -$11.51M -$21.14M $2.51M -$159.14M
Net cash flow from investing -$4.76M -$11.51M -$21.14M $2.51M -$159.14M
-Change in Payables and Accrued Expense $2.50M -$11.12M $10.64M -$1.63M $1.05M
Other Non-Cash Items $3,000.00 -$16,000.00 – $0.00 $0.00
-Change in Prepaid Assets $135,000.00 $15.22M -$10.06M $2.61M -$21.86M
Change in Working Capital $1.44M $4.10M $4.57M $983,000.00 -$23.84M
Depreciation & Depletion & Amortization $59,000.00 $62,000.00 $59,000.00 $64,000.00 $45,000.00
Net Income from Continuing Operations -$64.14M -$48.44M -$74.92M -$72.01M -$17.36M
Operating Cash Flow -$39.21M -$30.60M -$40.88M -$32.77M -$37.67M
Net PPE Purchase and Sale -$80,000.00 -$38,000.00 -$100,000.00 -$42,000.00 -$88,000.00
Net Cash Flow from Continuing Financing Activities $11.04M $11.07M $13.68M $5.89M $3.43M
Net Investment Purchase and Sale -$4.68M -$11.47M -$21.04M $2.55M -$159.05M
Free Cash Flow -$39.29M -$30.64M -$40.98M -$32.81M -$37.76M
Beginning Cash Balance $458.94M $491.32M $539.72M $563.86M $748.42M
Net Change in Cash -$32.94M -$31.05M -$48.33M -$24.37M -$193.38M
Effect of Exchange Rate Changes -$500,000.00 -$1.33M -$60,000.00 $222,000.00 $8.83M
Proceeds from Stock Option Exercised $11.04M $11.07M $13.68M $5.89M $3.43M
Gain/Loss from Continuing Operations $5.09M -$4.32M $15.43M $23.58M -$11.22M
Financing Cash Flow $11.04M $11.07M $13.68M $5.89M $3.43M
Net cash flow from continuing operations -$39.21M -$30.60M -$40.88M -$32.77M -$37.67M
-Change In Other Working Capital – – $3.99M $0.00 -$3.03M
Net Other Financing Charges – – $0.00 $0.00 $0.00
Net Common Stock Issuance – – $0.00 – –

Balance sheet

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Goodwill and Other Intangible Assets $407,000.00 $534,000.00 $170,000.00 $208,000.00 $0.00
-Available for Sale Securities $92.61M – – – –
Investments and Advances $92.61M $0.00 – – –
-Gross PPE $568,000.00 $673,000.00 $101,000.00 $154,000.00 $232,105.25
Total Non-Current Assets $93.58M $1.21M $306,000.00 $518,000.00 $1.03M
Restricted Cash $1.32M $0.00 – – –
Prepaid Assets $14.99M $7.92M $4.46M $8.18M $1.69M
-Other Receivables $22.92M $20.98M $875,000.00 – –
-Taxes Receivable $231,000.00 $321,000.00 $1.01M $2.07M $4.86M
Receivables $23.15M $21.31M $1.88M $2.07M $4.86M
Total Assets $769.28M $864.62M $347.10M $478.50M $67.69M
Total Current Assets $675.70M $863.41M $346.79M $477.98M $66.66M
-Short Term Investments $146.24M $62.45M $0.00 – –
Cash and Cash Equivalents & Short-Term Investments $636.24M $834.19M $340.45M $467.73M $60.11M
Net PPE $568,000.00 $673,000.00 $101,000.00 $154,000.00 $215,121.94
-Cash and Cash Equivalents $490.00M $771.74M $340.45M $467.73M $60.11M
Gains/Losses Not Affecting Retained Earnings $4.79M $4.47M $4.42M $4.42M $669,142.46
Retained Earnings -$762.39M -$558.57M -$316.97M -$140.04M -$39.26M
Additional Paid-In Capital $1.43B $1.30B $590.77M $555.63M –
-Common Stock $14.28M $13.44M $10.17M $10.06M $94.97M
Capital Stock $14.28M $13.44M $10.17M $10.06M $94.97M
Stockholders' Equity $683.43M $757.50M $288.39M $430.07M $56.37M
Total Equity $683.43M $757.50M $288.39M $430.07M $56.37M
-Long Term Capital Lease Obligation $66,000.00 $202,000.00 $0.00 $60,000.00 $125,676.50
Long Term Debt and Capital Lease Obligation $66,000.00 $202,000.00 $0.00 $60,000.00 $125,676.50
Total Liabilities $85.85M $107.12M $58.70M $48.43M $11.31M
Total Current Liabilities $85.79M $106.92M $49.90M $36.06M $11.19M
-Accounts Payable $8.97M $4.74M $16.92M $11.85M $7.04M
Other Current Liabilities $57.27M $82.31M $12.57M $4.15M $1,132.22
Total Non-Current Liabilities $66,000.00 $202,000.00 $8.81M $12.37M $125,676.50
Current Deferred Liabilities $3.99M $6.01M $8.94M $13.87M $0.00
-Current Capital Lease Obligation $136,000.00 $246,000.00 $60,000.00 $66,000.00 $60,007.70
Short-Term Debt and Capital Lease Obligation $136,000.00 $246,000.00 $60,000.00 $66,000.00 $60,007.70
Payables $8.97M $4.74M $16.92M $11.85M $10.18M
Current Accrued Expenses $6.07M $4.89M $8.01M $4.12M $424,582.78
Non-Current Prepaid Assets – – $35,000.00 $156,000.00 $0.00
Non-Current Deferred Liabilities – – $1.02M $4.79M $0.00
Derivative Product Liabilities – – $7.79M $7.52M $0.00
-Total Tax Payable – – – – $3.14M
-Accumulated Depreciation – – – – -$16,983.31
Non-Current Note Receivables – – – – $812,934.49

Income statement

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Diluted EPS -$1.72 -$2.56 -$2.15 -$1.19 -$0.51
Basic EPS -$1.72 -$2.56 -$2.15 -$1.19 -$0.51
Net Income to Common Stockholders -$203.82M -$241.60M -$176.94M -$22.63M -$41.79M
Research & Development $141.83M $151.41M $159.42M $86.74M $28.97M
-General & Admin Expense $106.35M $70.45M $37.63M $19.51M $4.70M
Selling and Admin Expenses $106.35M $70.45M $37.63M $19.51M $5.68M
Operating Expense $248.19M $221.85M $197.06M $106.25M $34.65M
Total Operating Revenue $22.50M $45.56M $14.09M $102.69M $0.00
Total Revenue as Reported $22.50M $45.56M $14.09M $102.69M $0.00
Operating Profit -$225.68M -$176.29M -$182.97M -$3.56M -$34.65M
Net Non-Operating Interest Income (Expense) $27.59M $16.88M $11.28M -$287,000.00 -$737,000.00
Non-Operating Interest Income $27.59M $16.88M $11.28M $0.00 $0.00
Net Income to Parent Company -$203.82M -$241.60M -$176.94M -$22.63M -$41.79M
Profit from Continuing Operations -$203.82M -$241.60M -$176.94M -$22.63M -$41.79M
Net Profit -$203.82M -$241.60M -$176.94M -$22.63M -$41.79M
Tax $0.00 -$1,000.00 $27,000.00 $0.00 $0.00
Pretax Profit -$203.82M -$241.60M -$176.91M -$22.63M -$41.79M
-Less:Restructuring and Mergern & Acquisition -$3.99M $37.01M $266,000.00 $707,000.00 –
Special Income (Charges) $3.99M -$37.01M -$266,000.00 -$707,000.00 -$883,000.00
Gain on Sale of Security -$9.72M -$45.18M -$4.96M -$10.08M $1.71M
Other Income (Expense) -$5.73M -$82.19M -$5.23M -$18.79M -$6.40M
Other Non-Operating Income (Expenses) – – – -$8.00M -$7.22M
Non-Operating Interest Expense – – – $287,000.00 $411,000.00
-Selling & Marketing Expense – – – – $977,000.00
-Less:Other Special Charges – – – – $883,000.00
Total Other Finance Costs – – – – $326,000.00

Discussion

No comments yet — be the first to weigh in on NAMS.

Leave a comment

Scroll to Top